ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs

Wang, Lexun; Zhang, Dongxing; Zhan, Wenjing; Zeng, Zhihuan; Yin, Jianying; Wang, Ke; Wang, Hong; Song, Lixia; Gu, Zhanhui; Guo, Caijuan; Zhong, Qin; Wang, Weixuan; Rong, Xianglu; Bei, Weijian; Guo, Jiao广东药学院; 1
Biomedicine and Pharmacotherapy2022-12DOI: 10.1016/j.biopha.2022.113831
2被引19阅读
引用收藏
分享

摘要

Background: Diabetes mellitus-related coronary heart disease (DM-CHD) is the most common cause of death in diabetic patients. Various studies have shown that Chinese medicine Fufang-Zhenzhu-Tiaozhi capsule (FTZ) has therapeutic effects on cardiovascular diseases. More research is required to determine the mechanism of FTZ protection against coronary atherosclerosis.Objective: To investigate the unique mechanism of FTZ in treatment of DM-CHD minipigs with coronary atherosclerosis.Methods: High-fat/high-sucrose/high-cholesterol diet combined with streptozotocin and coronary balloon injury were used to induce DM-CHD minipig model, which was then randomly divided into: DM-CHD model, DM-CHD treated with FTZ or positive drug (Metformin + Atorvastatin, M+A). After twenty-two weeks, ultrasonography, electrocardiography, and image detection were employed to detect cardiac functions and assess coronary artery stenosis and plaque. Human umbilical vein endothelial cells (HUVECs) were treated high glucose or/and FTZ. Pigs tissues and treated-cells were collected for further testing.Results: In DM-CHD minipigs, FTZ treatment significantly reduced disordered glycolipid metabolism similar as M+A administration. FTZ and M+A also alleviated coronary stenosis and myocardial injury. In addition, I Kappa B and NF-Kappa B phosphorylation levels, as well as the protein levels of IL-1 beta, Bax, cleave-Caspase 3, Bcl-2, and alpha-SMA were dramatically increased in the DM-CHD coronary artery, whereas CD31 and VE-cadherin expressions were decreased. Similar to M+A, FTZ reversed these protein levels in the DM-CHD coronary artery. Furthermore, FTZ ameliorated the damage and high migration activity of HUVECs induced by high glucose.

学科与关键词

关键词
Coronary atherosclerosisChinese medicineInflammationApoptosisEndothelial-mesenchymal transition
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-12
卷期
第 156 卷
页码
113831
DOI
10.1016/j.biopha.2022.113831
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2018YFC1704200]; Major Basic and Applied Basic Research Projects of Guangdong Province of China [2019B030302005]; Key Project of the National Natural Science Foundation of China [81530102]; Basic and Applied Basic Research Project of Guangdong Province of China [2018A030313391, 2019A1515110123, 2020A1515010155, 2021A1515012553]; "Innovation and Strengthening University Project" Subsidized Project of Guangdong Pharmaceutical University [2018KTSCX112]

作者

  • W

    Wang, Lexun (第一作者)

    guangdong pharmaceut univ

  • Z

    Zhang, Dongxing

    guangdong pharmaceut univ

查看全部 15 位作者收起作者
  • Z

    Zhan, Wenjing

    guangdong pharmaceut univ

  • Z

    Zeng, Zhihuan

  • Y

    Yin, Jianying

    guangdong pharmaceut univ

  • W

    Wang, Ke

    guangdong pharmaceut univ

  • W

    Wang, Hong

    guangdong pharmaceut univ

  • S

    Song, Lixia

    guangdong pharmaceut univ

  • G

    Gu, Zhanhui

    guangdong pharmaceut univ

  • G

    Guo, Caijuan

    guangdong pharmaceut univ

  • Z

    Zhong, Qin

    guangdong pharmaceut univ

  • W

    Wang, Weixuan

    guangdong pharmaceut univ

  • R

    Rong, Xianglu

    guangdong pharmaceut univ

  • B

    Bei, Weijian

    guangdong pharmaceut univ

  • G

    Guo, Jiao

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417